theresa mullin - director - fda cder office of

U S DEPARTMENT OF HEALTH AND HUMAN SERVICES + + + + +

2007/10/4Evaluation and Research FDA THERESA MULLIN PhD Director Office of Planning and Informatics FDA WADE W ACKERMAN Office of Chief Counsel FDA JANE A AXELRAD JD Associate Director for Policy Center for Drug Evaluation and

DIA 2016 Annual Meeting: #412: CDER Town Hall

Theresa Mullin Ph D serves as CDER's Associate Director for Strategic Initiatives She leads Patient-Focused Drug Development which includes implementation of the 21st Century Cures Act She leads the CDER International program and heads the FDA

Theresa Mullin Named CDER Associate Director For

Long-time FDAer Theresa Mullin has been appointed to the new position of associate director for strategic initiatives in the Center for Drug Evaluation and Research's Office of the Center Director (OCD) FDA revealed Monday (March 5) Mullin will oversee areas of

DIA 2019 Global Annual Meeting: #208: Patient Focus as

Theresa Mullin Ph D serves as CDER's Associate Director for Strategic Initiatives She leads Patient-Focused Drug Development which includes implementation of the 21st Century Cures Act She leads the CDER International program and heads the FDA

Theresa Mullin 2019 daag io

Theresa Mullin Associate Director for Strategic Initiatives CDER FDA Serves as principal advisor on strategy leads FDA Patient Focused Drug Development leads the New Inspection Protocol Project and heads FDA delegation to the International Council on Harmonization

CDER's THERESA MULLIN ON BIOSIMILAR PROGRAM CHALLENGES

CDER's THERESA MULLIN ON BIOSIMILAR PROGRAM CHALLENGES We have had a number of learnings and observations about how the program is going One of the things that has come up is that there has been a convergence and the emergence of novel legal issues and complex scientific issues

Theresa Mullin 2019 daag io

Theresa Mullin Associate Director for Strategic Initiatives CDER FDA Serves as principal advisor on strategy leads FDA Patient Focused Drug Development leads the New Inspection Protocol Project and heads FDA delegation to the International Council on Harmonization

FDA's Mullin Tapped for New Position in CDER's Office of

FDA announced on Monday that Janet Woodcock director of FDA's Center for Drug Evaluation and Research (CDER) has appointed Theresa Mullin to the new position of CDER Associate Director for Strategic Initiatives in the Office of the Center Director (OCD) effective immediately br /

Regulatory Submissions Information and Document Management

Theresa Mullin PhD Director Office of Strategic Programs CDER FDA • Exhibit Hall with numerous vendors • Expert perspectives from industry regulatory and vendors worldwide • Wait Wait Don't Tell Me! Your Regulatory War Stories Dinner on the Town

Theresa Mullin 2019 daag io

Theresa Mullin Associate Director for Strategic Initiatives CDER FDA Serves as principal advisor on strategy leads FDA Patient Focused Drug Development leads the New Inspection Protocol Project and heads FDA delegation to the International Council on Harmonization

FDA and Manufacturers Map Out PDUFA Reform Priorities

Theresa Mullin director of CDER's Office of Strategic Programs has the job of keeping the PDUFA negotiations on track She noted that PDUFA V focused on enhancing the review program for important new drugs achieving an increase in first-cycle approvals through

CDER's THERESA MULLIN ON BIOSIMILAR PROGRAM CHALLENGES

CDER's THERESA MULLIN ON BIOSIMILAR PROGRAM CHALLENGES We have had a number of learnings and observations about how the program is going One of the things that has come up is that there has been a convergence and the emergence of novel legal issues and complex scientific issues

FDA: Past Present and Future

2018/10/19Moderated by Theresa Mullin PhD Associate Director for Strategic Initiatives CDER FDA 21 st Century Citizen Pharma: The FDA Patient Focused Drug Development Jordan Paradise JD Georgia Reithal Professor of Law Loyola University Chicago School of Law

Dr Theresa Mullin to Join CDER

Theresa Mullin PhD will join CDER on September 24 2007 as the associate director for analysis and strategic initiatives As associate director she will lead CDER's long-range planning and strategic modernization initiatives Mullin previously worked as the

DIA 2019 Global Annual Meeting: #208: Patient Focus as

Theresa Mullin Ph D serves as CDER's Associate Director for Strategic Initiatives She leads Patient-Focused Drug Development which includes implementation of the 21st Century Cures Act She leads the CDER International program and heads the FDA

DIA 2019 Global Annual Meeting: #139: Developing

Theresa Mullin Ph D serves as CDER's Associate Director for Strategic Initiatives She leads Patient-Focused Drug Development which includes implementation of the 21st Century Cures Act She leads the CDER International program and heads the FDA

FDA and Manufacturers Map Out PDUFA Reform Priorities

Theresa Mullin director of CDER's Office of Strategic Programs has the job of keeping the PDUFA negotiations on track She noted that PDUFA V focused on enhancing the review program for important new drugs achieving an increase in first-cycle approvals through

FDA and Manufacturers Map Out PDUFA Reform Priorities

Theresa Mullin director of CDER's Office of Strategic Programs has the job of keeping the PDUFA negotiations on track She noted that PDUFA V focused on enhancing the review program for important new drugs achieving an increase in first-cycle approvals through

FDA Seeks Smooth PDUFA Renewal Process

Theresa Mullin director of CDER's Office of Strategic Programs has the job of keeping the PDUFA negotiations on track She noted that PDUFA V focused on enhancing the review program for important new drugs achieving an increase in first-cycle approvals through

DIA 2019 Global Annual Meeting: #139: Developing

Theresa Mullin Ph D serves as CDER's Associate Director for Strategic Initiatives She leads Patient-Focused Drug Development which includes implementation of the 21st Century Cures Act She leads the CDER International program and heads the FDA

Theresa Mullin Director Office of Strategic Programs Center for Drug Evaluation and Research U S Food and Drug Administration Dr Theresa Mullin serves as Director of OSP whose mission is to transform and modernize drug regulatory operations leading the CDER international program data standards business informatics lean management program analysis and major drug user fee

Theresa Mullin Director Office of Strategic Programs Center for Drug Evaluation and Research U S Food and Drug Administration Dr Theresa Mullin serves as Director of OSP whose mission is to transform and modernize drug regulatory operations leading the CDER international program data standards business informatics lean management program analysis and major drug user fee

Theresa Mullin Named CDER Associate Director For

Long-time FDAer Theresa Mullin has been appointed to the new position of associate director for strategic initiatives in the Center for Drug Evaluation and Research's Office of the Center Director (OCD) FDA revealed Monday (March 5) Mullin will oversee areas of

Online customer service

Welcome ! If you have any questions or suggestions about our products and services,please feel free to tell us anytime!